Junya Mita
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Mac-2 Binding Protein Glycosylation Isomer (M2BPGi)-Based Risk Stratification Refined by Tumor Metabolic Activity in Hepatocellular Carcinoma.
Journal: Annals of gastroenterological surgery
Published: August 11, 2026
A case of rapidly progressive liver failure with multiple vascular proliferative lesions
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: July 12, 2026
Insights Into the Revision of Heart Transplant Allocation Criteria - Analysis of Waitlist Mortality and Transplant Probability for Adult Heart Transplant Candidates in the Nationwide Registry Data of Japan.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: July 12, 2026
Time Matters More Than Distance: The Impact of Transport Logistics on Total Ischemic Time and Survival After Deceased-Donor Liver Transplantation.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 14, 2026
Nuclear Pan-Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 15, 2026
Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy.
Journal: Hepatology communications
Published: February 23, 2026
ASO Visual Abstract: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.
Journal: Annals of surgical oncology
Published: February 19, 2026
Correction: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.
Journal: Annals of surgical oncology
Published: January 31, 2026
Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.
Journal: Annals of surgical oncology
Published: November 21, 2025
Dual Escape From Disulfidptosis and Ferroptosis Drives Highly Aggressive, Hypermetabolic Hepatocellular Carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 09, 2025
PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived Model.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 27, 2025
Patatin-Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 08, 2025
Last Updated: 09/26/2026